Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001510580-17-000011
Filing Date
2017-08-08
Accepted
2017-08-08 08:02:34
Documents
70
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kite10q6-30x17.htm 10-Q 1190648
2 EXHIBIT 31.1 kiteex-31106x30x17.htm EX-31.1 9984
3 EXHIBIT 31.2 kiteex-31206x30x17.htm EX-31.2 9938
4 EXHIBIT 32.1 kiteex-32106x30x17.htm EX-32.1 4892
5 EXHIBIT 32.2 kiteex-32206x30x17.htm EX-32.2 5029
  Complete submission text file 0001510580-17-000011.txt   6877664

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kite-20170630.xml EX-101.INS 1459597
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kite-20170630.xsd EX-101.SCH 52515
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kite-20170630_cal.xml EX-101.CAL 73496
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kite-20170630_def.xml EX-101.DEF 296126
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kite-20170630_lab.xml EX-101.LAB 684381
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kite-20170630_pre.xml EX-101.PRE 448529
Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Filer) CIK: 0001510580 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-36508 | Film No.: 171013283
SIC: 2836 Biological Products, (No Diagnostic Substances)